文献速递神经介入DSA

三维旋转血管造影筛选无邻近分支动脉粥样硬化病变的症状性颅内狭窄支架辅助血管成形术随机试验

Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis without Adjacent Branch Atheromatous Disease: A Randomized Trial with Patients Selected by Using Three-Dimensional Rotational Angiography.
PubMed 文献 · Radiology · 2025-01-01

本单中心前瞻性随机开放标签盲法终点试验于2006至2022年在香港纳入150例症状性颅内动脉粥样硬化性狭窄(70%-99%)患者,经三维旋转血管造影排除邻近分支动脉粥样硬化病变后随机分为支架置入组(74例)与药物治疗组(76例)。支架置入组30天内或30天至1年缺血性卒中等主要终点累积发生率与药物组无显著差异(16% vs 24%;HR 0.66,95%CI 0.32-1.36;P=0.26)。1年狭窄百分比支架组低于药物组(33%±22 vs 67%±18;P<0.001)。

要点

  • 三维旋转血管造影排除邻近分支动脉粥样硬化病变后,支架置入未降低主要终点累积发生率。
  • 支架组1年狭窄百分比为33%±22,低于药物组的67%±18(P<0.001)。
  • 主要终点支架组12/74(16%)vs 药物组18/76(24%),HR 0.66(95%CI 0.32-1.36),P=0.26。

核心结论

  • 在无邻近分支动脉粥样硬化病变的症状性颅内动脉粥样硬化性狭窄患者中,颅内支架置入未降低30天内卒中或死亡以及30天至1年卒中的累积发生率。

研究设计与样本

  • 单中心前瞻性随机开放标签盲法终点试验,2006至2022年在香港开展,共150例患者随机分为支架置入组(74例)与药物治疗组(76例),入组为短暂性脑缺血发作或缺血性卒中归因于重度颅内动脉粥样硬化性狭窄(70%-99%)者,随机化在合格事件6周内完成,所有患者接受三维旋转血管造影,邻近目标狭窄的严重分支动脉粥样硬化病变者被排除,支架置入在局部麻醉下进行,采用Cox比例风险模型比较累积发生率。

诊断标准与关键数值

  • 主要终点为30天内短暂性脑缺血发作、缺血性卒中、颅内出血和死亡的复合终点,以及30天至1年任何缺血性卒中;支架置入组 vs 药物治疗组主要终点12/74(16%)vs 18/76(24%),HR 0.66(95%CI 0.32,1.36),P=0.26;同血管供血区缺血性卒中或短暂性脑缺血发作9/74(12%)vs 15/76(20%),HR 0.59(95%CI 0.26,1.35),P=0.21;1年任何卒中10/74(14%)vs 17/76(22%),HR 0.57(95%CI 0.27,1.24),P=0.16;1年狭窄百分比支架置入组33%±22 vs 药物治疗组67%±18,P<0.001。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Use of stents for symptomatic intracranial atherosclerotic stenosis (ICAS) was found to be harmful in previous randomized trials, in which perforator stroke was a notable procedural complication. It was unclear if excluding patients with concurrent branch atheromatous disease (BAD) adjacent to the target intracranial stenosis may reduce perforator jailing. Purpose To compare the safety and efficacy of intracranial stent placement (hereafter, stenting) versus medical therapy in participants with high-grade symptomatic ICAS and adjacent BAD excluded with three-dimensional rotational angiography (3DRA). Materials and Methods In this single-center, prospective, randomized, open-label, blinded end-point trial conducted in Hong Kong from 2006 to 2022, participants with transient ischemic attack (TIA) or ischemic stroke attributed to severe ICAS (70%-99%) were randomized to intracranial stenting under local anesthesia or medical therapy within 6 weeks of a qualifying event. Participants underwent 3DRA, and participants with severe BAD adjacent to the target stenosis were excluded. The primary end point was a composite of TIA, ischemic stroke, intracranial hemorrhage, and death within 30 days or any ischemic stroke from 30 days to 1 year. The secondary end points were ischemic stroke or TIA in the same artery territory (SIT), any strokes, and percentage of stenosis at 1 year. Cumulative incidences of end points were compared using Cox proportional hazard models. Results A total of 150 participants (mean age, 61 years ± 9.5 [SD], 45 female participants) were randomized into stenting (n = 74) and medical therapy (n = 76) groups. There was no evidence of between-group differences in the cumulative incidence of the primary end point (stenting vs medical therapy, respectively: 12 of 74 [16%] vs 18 of 76 [24%]; hazard ratio [HR], 0.66 [95% CI: 0.32, 1.36]; P = .26), SIT (nine of 74 [12%] vs 15 of 76 [20%]; HR, 0.59 [95% CI: 0.26, 1.35]; P = .21), or any strokes at 1 year (10 of 74 [14%] vs 17 of 76 [22%]; HR, 0.57 [95% CI: 0.27, 1.24]; P = .16). Percentage stenosis at 1 year was lower with intracranial stenting (33% ± 22 vs 67% ± 18, respectively; P < .001). Conclusion In participants with symptomatic ICAS without BAD adjacent to the target stenosis, intracranial stenting did not result in a reduction in the cumulative incidence of stroke or death at 30 days or stroke from 30 days to 1 year. Center for Clinical Research and Biostatistics Clinical Trial Registry (The Chinese University of Hong Kong)/Chinese Clinical Trials Registry Identifier: CUHK-CCT00116 Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Wojak in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ip BY, Ma SH, Lui WT, et al. Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis without Adjacent Branch Atheromatous Disease: A Randomized Trial with Patients Selected by Using Three-Dimensional Rotational Angiography. Radiology. 2025. PMID: 40590690. doi:10.1148/radiol.243860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。